Importantly, in clinical tumour samples, RN181 was reversely correlated with the expression of cyclin D1 and CDK4, highlighting the role of the RN181–cyclin D1/CDK4 pathway in the control of tumour growth. The gene discussed is CCND1; the disease is neoplasm.